Welcome!

News Feed Item

Spastic Cerebral Palsy Global Clinical Trials Review, H2, 2014

LONDON, Aug. 11, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Spastic Cerebral Palsy Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/2280941/Spastic-Cerebral-Palsy-Global-Clinical-Trials-Review-H2-2014.html

Spastic Cerebral Palsy Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Spastic Cerebral Palsy Global Clinical Trials Review, H2, 2014" provides data on the Spastic Cerebral Palsy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Spastic Cerebral Palsy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Spastic Cerebral Palsy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Spastic Cerebral Palsy 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Spastic Cerebral Palsy to Central Nervous System Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Spastic Cerebral Palsy to Central Nervous System Clinical Trials 17
Clinical Trials in E7 Countries by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Unaccomplished Trials of Spastic Cerebral Palsy 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Spastic Cerebral Palsy Therapeutics Clinical Trials 27
Prominent Drugs 28
Clinical Trial Profiles 29
Clinical Trial Overview of Top Companies 29
Medy-Tox Inc. 29
Clinical Trial Overview of Medy-Tox Inc. 29
GlaxoSmithKline plc 30
Clinical Trial Overview of GlaxoSmithKline plc 30
Daiichi Sankyo Company, Limited 31
Clinical Trial Overview of Daiichi Sankyo Company, Limited 31
Clinical Trial Overview of Top Institutes / Government 32
All India Institute of Medical Sciences 32
Clinical Trial Overview of All India Institute of Medical Sciences 32
Gujarat Ayurved University 33
Clinical Trial Overview of Gujarat Ayurved University 33
Azienda Ospedaliera Istituti Clinici Di Perfezionamento 34
Clinical Trial Overview of Azienda Ospedaliera Istituti Clinici Di Perfezionamento 34
Duke University Medical Center 35
Clinical Trial Overview of Duke University Medical Center 35
Wright State University 36
Clinical Trial Overview of Wright State University 36
ALYN Pediatric and Adolescent Rehabilitation Center 37
Clinical Trial Overview of ALYN Pediatric and Adolescent Rehabilitation Center 37
Erasmus MC 38
Clinical Trial Overview of Erasmus MC 38
Chang Gung Memorial Foundation 39
Clinical Trial Overview of Chang Gung Memorial Foundation 39
National Center for Complementary and Alternative Medicine 40
Clinical Trial Overview of National Center for Complementary and Alternative Medicine 40
Stanford University 41
Clinical Trial Overview of Stanford University 41
Five Key Clinical Profiles 42
Appendix 57
Abbreviations 57
Definitions 57
Research Methodology 58
Secondary Research 58
About GlobalData 59
Contact Us 59
Disclaimer 59
Source 59

List of Tables

Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials by Region, 2014* 7
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Spastic Cerebral Palsy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Spastic Cerebral Palsy Therapeutics Clinical Trials, Europe, Top Countries, 2014* 11
Spastic Cerebral Palsy Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Spastic Cerebral Palsy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Proportion of Spastic Cerebral Palsy to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14
Spastic Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Spastic Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Spastic Cerebral Palsy to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 17
Spastic Cerebral Palsy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials by Phase, 2014* 19
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 20
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Spastic Cerebral Palsy Therapeutics, Global, Terminated Clinical Trials, 2014* 23
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Spastic Cerebral Palsy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 25
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 26
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 27
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 28
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Medy-Tox Inc., 2014* 29
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 30
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2014* 31
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2014* 32
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Gujarat Ayurved University, 2014* 33
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliera Istituti Clinici Di Perfezionamento, 2014* 34
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University Medical Center, 2014* 35
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Wright State University, 2014* 36
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by ALYN Pediatric and Adolescent Rehabilitation Center, 2014* 37
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2014* 38
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Chang Gung Memorial Foundation, 2014* 39
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Complementary and Alternative Medicine, 2014* 40
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014* 41

List of Figures

Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Spastic Cerebral Palsy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Spastic Cerebral Palsy Therapeutics Clinical Trials, Europe, Top Countries (%), 2014* 11
Proportion of Spastic Cerebral Palsy to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14
Spastic Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Spastic Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Spastic Cerebral Palsy to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 17
Spastic Cerebral Palsy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials by Phase (%), 2014* 19
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 20
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Spastic Cerebral Palsy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 25
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 26
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 27
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 28
GlobalData Methodology 58


Read the full report:
Spastic Cerebral Palsy Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/2280941/Spastic-Cerebral-Palsy-Global-Clinical-Trials-Review-H2-2014.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

 

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
DX World EXPO, LLC, a Lighthouse Point, Florida-based startup trade show producer and the creator of "DXWorldEXPO® - Digital Transformation Conference & Expo" has announced its executive management team. The team is headed by Levent Selamoglu, who has been named CEO. "Now is the time for a truly global DX event, to bring together the leading minds from the technology world in a conversation about Digital Transformation," he said in making the announcement.
"Space Monkey by Vivent Smart Home is a product that is a distributed cloud-based edge storage network. Vivent Smart Home, our parent company, is a smart home provider that places a lot of hard drives across homes in North America," explained JT Olds, Director of Engineering, and Brandon Crowfeather, Product Manager, at Vivint Smart Home, in this SYS-CON.tv interview at @ThingsExpo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
SYS-CON Events announced today that Conference Guru has been named “Media Sponsor” of the 22nd International Cloud Expo, which will take place on June 5-7, 2018, at the Javits Center in New York, NY. A valuable conference experience generates new contacts, sales leads, potential strategic partners and potential investors; helps gather competitive intelligence and even provides inspiration for new products and services. Conference Guru works with conference organizers to pass great deals to gre...
DevOps is under attack because developers don’t want to mess with infrastructure. They will happily own their code into production, but want to use platforms instead of raw automation. That’s changing the landscape that we understand as DevOps with both architecture concepts (CloudNative) and process redefinition (SRE). Rob Hirschfeld’s recent work in Kubernetes operations has led to the conclusion that containers and related platforms have changed the way we should be thinking about DevOps and...
The Internet of Things will challenge the status quo of how IT and development organizations operate. Or will it? Certainly the fog layer of IoT requires special insights about data ontology, security and transactional integrity. But the developmental challenges are the same: People, Process and Platform. In his session at @ThingsExpo, Craig Sproule, CEO of Metavine, demonstrated how to move beyond today's coding paradigm and shared the must-have mindsets for removing complexity from the develop...
In his Opening Keynote at 21st Cloud Expo, John Considine, General Manager of IBM Cloud Infrastructure, led attendees through the exciting evolution of the cloud. He looked at this major disruption from the perspective of technology, business models, and what this means for enterprises of all sizes. John Considine is General Manager of Cloud Infrastructure Services at IBM. In that role he is responsible for leading IBM’s public cloud infrastructure including strategy, development, and offering m...
The next XaaS is CICDaaS. Why? Because CICD saves developers a huge amount of time. CD is an especially great option for projects that require multiple and frequent contributions to be integrated. But… securing CICD best practices is an emerging, essential, yet little understood practice for DevOps teams and their Cloud Service Providers. The only way to get CICD to work in a highly secure environment takes collaboration, patience and persistence. Building CICD in the cloud requires rigorous ar...
Companies are harnessing data in ways we once associated with science fiction. Analysts have access to a plethora of visualization and reporting tools, but considering the vast amount of data businesses collect and limitations of CPUs, end users are forced to design their structures and systems with limitations. Until now. As the cloud toolkit to analyze data has evolved, GPUs have stepped in to massively parallel SQL, visualization and machine learning.
"Evatronix provides design services to companies that need to integrate the IoT technology in their products but they don't necessarily have the expertise, knowledge and design team to do so," explained Adam Morawiec, VP of Business Development at Evatronix, in this SYS-CON.tv interview at @ThingsExpo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
To get the most out of their data, successful companies are not focusing on queries and data lakes, they are actively integrating analytics into their operations with a data-first application development approach. Real-time adjustments to improve revenues, reduce costs, or mitigate risk rely on applications that minimize latency on a variety of data sources. In his session at @BigDataExpo, Jack Norris, Senior Vice President, Data and Applications at MapR Technologies, reviewed best practices to ...
Widespread fragmentation is stalling the growth of the IIoT and making it difficult for partners to work together. The number of software platforms, apps, hardware and connectivity standards is creating paralysis among businesses that are afraid of being locked into a solution. EdgeX Foundry is unifying the community around a common IoT edge framework and an ecosystem of interoperable components.
"ZeroStack is a startup in Silicon Valley. We're solving a very interesting problem around bringing public cloud convenience with private cloud control for enterprises and mid-size companies," explained Kamesh Pemmaraju, VP of Product Management at ZeroStack, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
Large industrial manufacturing organizations are adopting the agile principles of cloud software companies. The industrial manufacturing development process has not scaled over time. Now that design CAD teams are geographically distributed, centralizing their work is key. With large multi-gigabyte projects, outdated tools have stifled industrial team agility, time-to-market milestones, and impacted P&L stakeholders.
"Akvelon is a software development company and we also provide consultancy services to folks who are looking to scale or accelerate their engineering roadmaps," explained Jeremiah Mothersell, Marketing Manager at Akvelon, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
Enterprises are adopting Kubernetes to accelerate the development and the delivery of cloud-native applications. However, sharing a Kubernetes cluster between members of the same team can be challenging. And, sharing clusters across multiple teams is even harder. Kubernetes offers several constructs to help implement segmentation and isolation. However, these primitives can be complex to understand and apply. As a result, it’s becoming common for enterprises to end up with several clusters. Thi...